SCHEMBL2332287

SCHEMBL2332287

CCCCCCCCCO[Sn](OCCCCCCCCC)(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.41
CES2 O00748 1/20 0.37
MEN1 O00255 1/20 0.31
THRB P10828 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2328240 1.00 CES1 (0.41) CES1CES2MEN1THRBHTT
SCHEMBL2325376 1.00 CES1 (0.41) CES1CES2MEN1THRBHTT
SCHEMBL2321196 1.00 CES1 (0.41) CES1CES2MEN1THRBHTT
SCHEMBL2324761 1.00 CES1 (0.41) CES1CES2MEN1THRBHTT
SCHEMBL2325466 0.98 CES1 (0.38) CES1CES2
SCHEMBL2347899 0.93 CES1 (0.39) CES1CES2
SCHEMBL2351330 0.93 CES1 (0.39) CES1CES2
SCHEMBL2329009 0.93 CES1 (0.39) CES1CES2
SCHEMBL2339486 0.93 CES1 (0.39) CES1CES2
SCHEMBL2343844 0.93 CES1 (0.39) CES1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1760085-B1 PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES ASAHI KASEI CHEMICALS CORP (JP) 2014-02-26 EP disclosed
EP-1987881-B1 METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE ASAHI KASEI CHEMICALS CORP (JP) 2011-08-17 EP disclosed
US-7842828-B2 Method for separating out and recovering dialkyltin dialkoxide ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-11-30 US disclosed
US-20100160662-A1 Method for Separating Out and Recovering Dialkyltin Dialkoxide ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-06-24 US disclosed
US-7541482-B2 Process for production of alkyltin alkoxides ASAHI KASEI CHEMICALS CORPORATION (JP) 2009-06-02 US disclosed
US-20080275262-A1 Process for Production of Alkyltin Alkoxides ASAHI KASEI CHEMICALS CORPORATION (JP) 2008-11-06 US disclosed
EP-1987881-A1 METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE Asahi Kasei Chemicals Corporation (JP) 2008-11-05 EP disclosed
EP-1760085-A1 PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES Asahi Kasei Chemicals Corporation (JP) 2007-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160662-A1 Method for Separating Out and Recovering Dialkyltin Dialkoxide ALOX5, ALOX15B, ALOX15 CES1 626/4885CES2 826/4885MEN1 3047/4885
US-20080275262-A1 Process for Production of Alkyltin Alkoxides ALK, MOGAT2, SOAT2 CES1 4234/4885CES2 3023/4885MEN1 2854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.